Published in Pharma Investments, Ventures and Law Weekly, December 31st, 2006
The panel of academic, industry and government representatives concluded that several factors have impeded the development of novel treatments for mental illness including: incomplete understanding of the impact of mental illness on the brain; continued skepticism of results from animal models for certain disorders; an outdated paradigm of treatment and the industry preference toward so-called "me-too" drugs.
"We need to do better when treating...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly